![]() Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. | ![]() Cellink CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products. | ![]() Longboard Pharmaceuticals Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases. | |
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2020 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations London, GB HQ London, GB | Locations Göteborg, SE HQ Dardilly, FR Kyoto, JP Göteborg, SE Brighton, GB Blacksburg, US Boston, US | Locations San Diego, US HQ San Diego, US |
Employees | Employees 647 | Employees 851% decrease | Employees 5056% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) 2.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) kr74.2m (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods $86.6m (FY, 2025) | Cost of goods kr40.2m (FY, 2021) | Cost of goods N/A |
Gross profit | Gross profit ($10.7m) (FY, 2025) | Gross profit kr34.1m (FY, 2021) | Gross profit N/A |
Net income | Net income ($287.5m) (FY, 2025) | Net income (kr27.4m) (FY, 2021) | Net income ($54.4m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 281.7m | Total funding raised $ 4.1m | Total funding raised $ 56m |

CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products.
View company
Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases.
View company